期刊
SEMINARS IN NEUROLOGY
卷 34, 期 4, 页码 458-466出版社
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0034-1390394
关键词
autoimmune; limbic; encephalitis; neuronal antibodies
资金
- National Institute of Neurologic Disorders and Stroke at the National Institutes of Health, USA (JL) [R25NS065743]
- National Institutes of Health, USA (JD) [R01NS077851]
- Fondo Investigaciones Sanitarias, Spain (JD) [11/01780]
- Fundacio la Marato, Spain (JD) [TV3]
- ICREA Funding Source: Custom
In the past few years, many autoimmune encephalitides have been identified, with specific clinical syndromes and associated antibodies against neuronal surface antigens. There is compelling evidence that many of these antibodies are pathogenic and most of these encephalitides are highly responsive to immunotherapies. The clinical spectra of some of these antibody-mediated syndromes, especially those reported in only a few patients, are evolving. Others, such as anti-N-methyl-D-aspartate (NMDA) receptor encephalitis, are well characterized. Diagnosis involves recognizing the specific syndromes and identifying the antibody in a patient's cerebrospinal fluid (CSF) and/or serum. These syndromes are associated with variable abnormalities in CSF, magnetic resonance imaging, and electroencephalography. Treatment is often multidisciplinary and should be focused upon neutralizing the effects of antibodies and eliminating their source. Overlapping disorders have been noted, with some patients having more than one neurologic autoimmune disease. In other patients, viral infections such as herpes simplex virus encephalitis trigger robust antineuronal autoimmune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据